Hematology Analyzers Market Size

Hematology Analyzers Market size was valued at USD 6.22 billion in 2023 and is expected to exceed USD 13.6 billion by 2036, expanding at over 6.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of hematology analyzers is assessed at USD 6.53 billion. The market for hematology analyzers is mainly projected to grow owing to factors such as the growing number of blood donations and rising incidences of blood disorders.  In 2018, more than 210,000 people were diagnosed with hemophilia, which increased up to about 324,000 in the year 2019. Moreover, the rising use of hematology analyzers in research and development activities in various areas such as pharmacogenomics, genetic therapies, bleeding disorders, stem cell research, and proteomics is also expected to propel market growth. Furthermore, factors such as the rise in public awareness and the consolidation of diagnostic laboratory chains are expected to drive the market growth in the forecast period. Additionally, the rising adoption rate of automated hematology instruments and integration of AI-based hematology analyzers combined with growing preferences towards high sensitivity hematology testing is also anticipated to drive the market growth in the near future.